Literature DB >> 22099074

Glioblastoma multiforme and cerebral cavernous malformations: intersection of pathophysiologic pathways.

Matthew K Mian1, Brian V Nahed, Brian P Walcott, Christopher S Ogilvy, William T Curry.   

Abstract

Cerebral cavernous malformations (CCM) are known to occur in both sporadic and familial forms. To date, there has been no identified association of CCM with glioblastoma multiforme. We present a 69-year-old woman with a 14 year history of multiple CCM who developed progressive aphasia. She had no radiation exposure and had only undergone a single computed tomography scan in her entire life. MRI demonstrated irregular gadolinium enhancement in the area of a prior stable CCM, suspicious for a high grade tumor. Stereotactic biopsy revealed a glioblastoma multiforme. This is a unique case of glioblastoma multiforme arising from the "site" of a known CCM. We review the literature on the genetics of cavernous malformations and propose a mechanism for the tumorigenic potential of these vascular malformations.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22099074     DOI: 10.1016/j.jocn.2011.07.017

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Case report: glioblastoma multiforme complicating familial cavernous malformations.

Authors:  D M Wilson; B Cohen; K Keshari; H Vogel; G Steinberg; W Dillon
Journal:  Clin Neuroradiol       Date:  2013-08-14       Impact factor: 3.649

2.  Development of a cerebellar glioblastoma at the same location of a previously stable cavernous angioma.

Authors:  Diogo Goulart Corrêa; Luis Alcides Quevedo Cañete; Luiz Celso Hygino da Cruz
Journal:  Neurol Sci       Date:  2021-07-14       Impact factor: 3.307

3.  Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.

Authors:  Nicole Lambertz; Nicolai El Hindy; Ilonka Kreitschmann-Andermahr; Klaus Peter Stein; Philipp Dammann; Neriman Oezkan; Oliver Mueller; Ulrich Sure; Yuan Zhu
Journal:  BMC Cancer       Date:  2015-10-21       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.